Drox 250

Indications

• Susceptible infections due to sensitive Gram-positive and Gram-negative bacteria
• Urinary tract infections
• Skin and soft tissue infections
• Pharyngitis
• Tonsillitis

Dosage

Children: Child 1 month–11 years: 25 mg/kg 2–4 times a day (max. per dose 1 g).

Adults: 250 mg every 6 hours, alternatively 500 mg every 8 to 12 hours; increased to 1 to 1.5 g every 6 to 8 hours for severe infections.

Mechanism of action

Cefadroxil binds to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, inhibiting the third and last stage of bacterial cell wall synthesis. This action results in cell lysis, which is mediated by bacterial cell wall autolytic enzymes, such as autolysins. Cefadroxil may also interfere with an autolysin inhibitor, further promoting bacterial cell death.

Pharmacodynamics

As a first-generation cephalosporin, cefadroxil exhibits broad-spectrum antibacterial activity, particularly against Gram-positive organisms. It is commonly used for treating urinary tract infections and soft tissue infections, as well as respiratory tract infections like pharyngitis and tonsillitis. Its pharmacological effectiveness stems from its ability to disrupt peptidoglycan maturation in bacterial cell walls.

Pharmacokinetics

Cefadroxil is well-absorbed after oral administration and achieves peak plasma concentrations within 1 to 2 hours. It has a half-life of approximately 1 hour, with renal excretion being the primary route of elimination. Dosage adjustments may be necessary in patients with renal impairment, as the drug may accumulate.

Contra-indications

• Hypersensitivity to cefadroxil or any other cephalosporins
• History of immediate hypersensitivity to penicillin and other beta-lactams

Adverse effects

• Abdominal pain
• Diarrhoea
• Dizziness
• Eosinophilia
• Headache
• Leucopenia
• Nausea
• Neutropenia
• Pseudomembranous colitis
• Skin reactions
• Thrombocytopenia
• Vomiting
• Vulvovaginal candidiasis
• Agranulocytosis (rare)
• Hemolytic anemia (rare)
• Tubulointerstitial nephritis (reversible, rare)
• Severe cutaneous adverse reactions (SCARs, rare)

Interactions

• Increased risk of nephrotoxicity when used with other nephrotoxic agents
• Probenecid may increase levels by decreasing renal clearance

Precautions

• Use with caution in patients with renal impairment
• Monitor for signs of anaphylaxis
• Cross-sensitivity with penicillins and other beta-lactams

Pregnancy

Not known to be harmful during pregnancy.

Breast-feeding

Present in milk in low concentration, but generally considered appropriate to use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Capsule 500 mg
• Suspension for oral use
• Tablet 250 mg

Indications

• Heart disease prevention
• Weight management
• Digestive health
• Antioxidant support

Dosage

Children: There is no specific pediatric dosage for apples; they can be included in children's diets as part of healthy eating practices, with portion sizes adjusted based on age and dietary needs.

Adults: There is no specific dosage for apples; they can be consumed as part of a balanced diet. Generally, 1-2 medium apples per day is a common recommendation for health benefits.

Mechanism of action

The beneficial effects of apples are attributed to their rich content of polyphenols, flavonoids, and dietary fiber. These compounds have antioxidant properties that help reduce oxidative stress in the body, modulate lipid levels, and improve gut health by promoting the growth of beneficial gut bacteria.

Pharmacodynamics

The pharmacodynamic effects of apples are primarily linked to their ability to lower cholesterol levels, improve blood sugar control, and enhance satiety, which can contribute to weight management. The antioxidants present in apples may also play a role in reducing inflammation and preventing chronic diseases such as cardiovascular disease and certain cancers.

Pharmacokinetics

The pharmacokinetics of apples are not typically characterized in the same manner as pharmaceuticals. However, the digestion and absorption of the nutrients found in apples occur primarily in the gastrointestinal tract. Dietary fiber, particularly soluble fiber like pectin, is fermented by gut bacteria, producing short-chain fatty acids that contribute to various health benefits.

Pregnancy

Apples are generally safe to consume during pregnancy and can provide essential nutrients.

Breast-feeding

Apples are safe during breastfeeding and can be beneficial for both mother and infant.

Storage

Store apples in a cool, dry place. Refrigeration can prolong freshness.

Formulations

• whole apples
• apple juice
• apple cider
• dried apple slices

Indications

• Food preservative
• Treatment of urea cycle disorders
• Metabolic disorders involving benzoyl-CoA

Dosage

Children: Refer to the BNF for Children for specific dosing guidelines based on condition.

Adults: Refer to the BNF for specific dosing guidelines based on condition.

Mechanism of action

Benzoate acts mainly by inhibiting the growth of bacteria and fungi through its ability to lower the pH, creating an environment that is less favorable for microbial growth. It is also involved in metabolic pathways where it helps in the conjugation of toxic substances, facilitating their excretion from the body.

Pharmacodynamics

Benzoate is known for its antimicrobial properties, which are particularly effective against a wide range of fungi and bacteria. Its efficacy as a preservative is due to its ability to penetrate microbial cell membranes and disrupt their metabolic processes. Additionally, it has been observed to modulate various metabolic pathways, particularly those associated with aromatic compound degradation.

Pharmacokinetics

After ingestion, benzoate is rapidly absorbed in the gastrointestinal tract. It is metabolized primarily in the liver, where it undergoes conjugation with glycine to form hippurate, which is then excreted in the urine. The half-life of benzoate varies depending on individual metabolic rates but is generally short due to its efficient conversion and excretion.

Pregnancy

There is limited data on the use of benzoate in pregnancy. Consultation with healthcare professionals is advised before use.

Breast-feeding

Limited data is available on the excretion of benzoate in breast milk. Caution is recommended when administering to nursing mothers.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Dry eye syndrome
• Ocular lubrication
• Thickening agent in pharmaceutical formulations
• Food industry as a stabilizer and emulsifier

Dosage

Children: For paediatric use, refer to specific product guidelines and consult a healthcare professional for appropriate advice.

Adults: For dry eye treatment, apply as needed, typically 1 drop in each affected eye. Refer to specific product guidelines for exact formulation and frequency.

Mechanism of action

Carboxymethylcellulose works by forming a gel-like structure when it interacts with water, which helps retain moisture and provide lubrication. In ophthalmic applications, it acts as a protective agent for the ocular surface, reducing friction and providing comfort to patients with dry eye conditions.

Pharmacodynamics

The pharmacodynamic properties of carboxymethylcellulose are primarily related to its ability to increase viscosity and improve the stability of formulations. It does not undergo significant systemic absorption and exerts its effects locally, particularly in the gastrointestinal tract and on the ocular surface as a lubricant.

Pharmacokinetics

Carboxymethylcellulose is not absorbed significantly through the gastrointestinal tract when ingested, and its systemic bioavailability is negligible. When used in ophthalmic formulations, it acts locally on the eye without significant systemic effects. The elimination pathway is primarily through natural degradation and excretion of unabsorbed material.

Adverse effects

• Allergic reactions
• Skin irritation
• Gastrointestinal discomfort

Precautions

• Use with caution in patients with known hypersensitivity to cellulose derivatives
• Monitor for allergic reactions

Pregnancy

Carboxymethylcellulose is generally considered safe during pregnancy as it is not absorbed systemically.

Breast-feeding

Carboxymethylcellulose is considered safe during breastfeeding as it is not absorbed systemically.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Eye drops
• Oral suspensions
• Topical gels

Indications

• Hypovolemic shock
• Severe burns
• Postoperative fluid replacement
• Sepsis
• Trauma management

Dosage

Children: Refer to established guidelines for specific dosing, as it varies based on the type of colloidal solution used and the clinical condition being treated.

Adults: Refer to established guidelines for specific dosing, as it varies based on the type of colloidal solution used and the clinical condition being treated.

Mechanism of action

Colloidal solutions work by maintaining oncotic pressure in the blood, thus helping to retain fluid within the vascular system. This is primarily due to the large molecular weight of the colloidal particles, which cannot easily pass through capillary walls. The presence of colloids in the blood helps to draw water into the circulation, increasing blood volume and improving tissue perfusion.

Pharmacodynamics

The pharmacodynamics of colloidal solutions are centered on their ability to exert osmotic pressure, which helps maintain blood volume and pressure. This effect is particularly important in conditions such as hypovolemia and shock, where fluid replacement is necessary to restore hemodynamic stability. The efficacy of colloidal solutions can vary depending on the type of colloid used, as well as the underlying clinical condition being treated.

Pharmacokinetics

Colloidal solutions are typically administered intravenously and their pharmacokinetics can vary based on the specific formulation. Generally, colloids are distributed throughout the vascular compartment and have a longer duration of action compared to crystalloids, as they remain in circulation longer. The elimination of colloids is primarily through the reticuloendothelial system, where they are metabolized or eliminated by the liver and spleen. Factors such as particle size and composition can influence their distribution and clearance.

Adverse effects

• Allergic reactions
• Injection site reactions
• Nausea
• Vomiting
• Headache
• Fever

Precautions

• Use with caution in patients with known allergies to any component of the formulation
• Monitor for signs of hypersensitivity during administration
• Consider volume overload in patients with cardiac or renal impairment

Pregnancy

The safety of colloidal solutions during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether colloidal solutions are excreted in human milk. Caution should be exercised when administering to breastfeeding mothers.

Storage

Store at room temperature, protect from light, and do not freeze. Keep out of reach of children.

Formulations

• Colloidal silver
• Colloidal gold
• Colloidal iron
• Other metal colloids

Indications

• Monitoring respiratory function
• Assessment of metabolic status
• Management of respiratory acidosis
• Management of respiratory alkalosis

Dosage

Children: Dosing for interventions related to carbon dioxide levels in pediatric patients should be guided by clinical protocols and the BNF for Children.

Adults: Dosing for interventions related to carbon dioxide levels is typically based on clinical assessment and individual patient needs. Refer to clinical guidelines for specific scenarios.

Mechanism of action

Carbon dioxide acts primarily as a signaling molecule in the body, influencing respiratory drive and blood pH. It is produced during cellular respiration and is a critical component of the bicarbonate buffering system, which helps maintain acid-base homeostasis. Elevated levels of CO2 in the blood stimulate ventilation in the lungs, increasing the rate of gas exchange and facilitating the removal of excess CO2.

Pharmacodynamics

The pharmacodynamic effects of dioxides, particularly carbon dioxide, are closely related to its concentration in the blood. As CO2 levels increase, it leads to respiratory acidosis, which can stimulate the respiratory centers in the brain to increase ventilation. Conversely, low levels of CO2 can cause respiratory alkalosis, potentially leading to decreased respiratory drive. CO2 also plays a role in vasodilation and can affect blood flow and pressure through its influence on smooth muscle tone.

Pharmacokinetics

Carbon dioxide is produced endogenously during metabolic processes and is transported in the bloodstream primarily in three forms: dissolved in plasma, as bicarbonate ions (HCO3-), and bound to hemoglobin. The half-life of CO2 in the bloodstream is very short due to its rapid exchange with alveolar gas in the lungs. The elimination of CO2 occurs through exhalation, making it a dynamic component of respiratory physiology.

Pregnancy

Data on the effects of dioxide during pregnancy are limited. Caution is advised due to potential risks associated with exposure.

Breast-feeding

Limited data are available regarding the excretion of dioxide in human milk. Caution is recommended.

Storage

Store in a cool, dry place, away from direct sunlight and moisture.

Indications

• Electrolyte replacement
• Volume expansion in hypovolemic patients
• Management of hyponatremia
• Support in intravenous fluid therapy

Dosage

Children: Refer to the BNF for Children for appropriate dosing in paediatric patients, as dosages may vary based on the formulation and clinical condition.

Adults: Refer to specific product information or clinical guidelines for dosage recommendations, as disodium is often part of combination products.

Mechanism of action

Disodium compounds often function by providing sodium ions that are essential for various physiological processes. Sodium ions play a critical role in maintaining osmotic balance, nerve impulse transmission, and muscle contraction. In the context of intravenous solutions, disodium helps to restore electrolyte balance in patients.

Pharmacodynamics

The pharmacodynamics of disodium is primarily related to its role in electrolyte balance and fluid homeostasis. Sodium ions are vital for the function of excitable tissues, including neurons and muscle cells. Changes in sodium levels can affect blood pressure, hydration status, and overall cellular function.

Pharmacokinetics

The pharmacokinetics of disodium compounds depend on their specific formulation and route of administration. When administered intravenously, disodium is rapidly distributed in the extracellular fluid, where it helps to maintain osmotic pressure. Sodium is primarily excreted by the kidneys, and its levels can be influenced by fluid intake, dietary sodium, and renal function.

Pregnancy

Use with caution. Consult a healthcare provider for specific guidance.

Breast-feeding

Use with caution. Consult a healthcare provider for specific guidance.

Storage

Store at room temperature, away from moisture and direct sunlight.

Indications

• To enhance the palatability of oral medications
• To improve compliance in pediatric patients
• To mask unpleasant tastes of active pharmaceutical ingredients

Dosage

Children: Refer to specific formulations for guidance, as flavoring agents are typically used in very small quantities and are not dosed independently.

Adults: Refer to specific formulations for guidance, as flavoring agents are typically used in very small quantities and are not dosed independently.

Mechanism of action

Flavor compounds act primarily by stimulating taste receptors on the tongue, which can enhance the overall sensory experience of ingesting a product. Certain flavor compounds may also interact with olfactory receptors, contributing to the perception of flavor through smell. The stimulation of these receptors can lead to increased salivation and improved swallowing.

Pharmacodynamics

The use of flavoring agents in pharmaceuticals can influence compliance, particularly in children and individuals who may have difficulty swallowing pills. By enhancing the taste of a medication, these agents can reduce gag reflex and aversion, potentially improving therapeutic outcomes. However, the pharmacodynamic effects are largely dependent on the individual's taste preferences and sensitivities.

Pharmacokinetics

The pharmacokinetics of flavoring agents vary widely depending on the specific compounds used. Generally, these compounds are rapidly absorbed through the gastrointestinal tract upon ingestion, with their effects occurring within minutes. Some flavoring agents may undergo metabolism in the liver, while others may be excreted unchanged. The specific absorption, distribution, metabolism, and excretion (ADME) profiles depend on the chemical structure of each flavor compound.

Pregnancy

Generally considered safe, but specific flavoring agents may need to be evaluated individually.

Breast-feeding

Generally considered safe, but specific flavoring agents may need to be evaluated individually.

Storage

Store in a cool, dry place away from light and moisture.

Indications

• Chronic venous insufficiency
• Osteoarthritis
• Hypertension
• Diabetes
• Cardiovascular health
• Antioxidant support

Dosage

Children: Refer to a healthcare professional or product guidelines for pediatric dosing, as safety and efficacy have not been well established in children.

Adults: Refer to the specific product guidelines, as dosages can vary based on the formulation and concentration of the extract.

Mechanism of action

The active compounds in pine bark extract, particularly proanthocyanidins, exert their effects through several mechanisms. They enhance nitric oxide production, which leads to vasodilation and improved blood flow. Additionally, they inhibit the oxidation of low-density lipoprotein (LDL) cholesterol, thus contributing to cardiovascular health. The antioxidant properties help reduce oxidative stress and inflammation by scavenging free radicals and modulating inflammatory pathways.

Pharmacodynamics

Pine bark extract displays a range of pharmacodynamic effects, including vasodilatory, anti-inflammatory, and antioxidant properties. These effects can lead to improved circulation, reduced symptoms of chronic venous insufficiency, and potential benefits in conditions associated with oxidative stress. The anti-inflammatory effects may also contribute to pain relief in osteoarthritis and other inflammatory conditions.

Pharmacokinetics

The pharmacokinetics of pine bark extract are influenced by its route of administration, typically oral. After ingestion, proanthocyanidins are absorbed in the gastrointestinal tract and distributed throughout the body. They undergo metabolic conversion in the liver, with a half-life that can vary based on individual metabolism and formulation. Elimination occurs primarily through urine, with metabolites detectable for several hours post-administration.

Adverse effects

• Allergic reactions
• Skin irritation
• Headache
• Gastrointestinal disturbances

Precautions

• Use with caution in individuals with known allergies to pine products.
• Monitor for allergic reactions in sensitive individuals.

Pregnancy

Pine products should be used with caution during pregnancy. Limited data is available regarding the safety of pine in pregnancy, consult a healthcare provider before use.

Breast-feeding

Caution is advised when using pine products while breastfeeding. Consult a healthcare provider for safety information.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Essential oil
• Extracts
• Topical ointments

Indications

• Sweetening agent in food and beverages
• Ingredient in pharmaceutical formulations
• Source of quick energy

Dosage

Children: Refer to specific formulations and clinical guidelines for dosing, as sucrose does not have a standardized dosage. Typically used as needed for sweetening.

Adults: Refer to specific formulations and clinical guidelines for dosing, as sucrose does not have a standardized dosage. Typically used as needed for sweetening.

Mechanism of action

Sucrose is metabolized in the body to glucose and fructose, which are then used as energy sources. It does not have a specific pharmacological mechanism of action but contributes to energy metabolism via the glycolytic and citric acid pathways.

Pharmacodynamics

Upon ingestion, sucrose is hydrolyzed by the enzyme sucrase into its constituent monosaccharides, glucose and fructose. These monosaccharides are absorbed in the small intestine and enter the bloodstream, leading to a rise in blood glucose levels. This process provides a quick source of energy for cellular functions.

Pharmacokinetics

Sucrose is rapidly absorbed in the gastrointestinal tract after hydrolysis. Its absorption depends on the presence of sucrase in the intestine. Once in the bloodstream, glucose can be utilized by cells or stored as glycogen in the liver and muscles. The elimination half-life of sucrose itself is not well-defined as it is quickly broken down and utilized.

Pregnancy

Sucrose is generally regarded as safe during pregnancy when consumed in moderation as part of a balanced diet.

Breast-feeding

Sucrose is considered safe during breastfeeding when consumed in normal dietary amounts.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Oral solution
• Granules
• Tablets

Dosage

Children: Refer to product-specific guidelines or consult a healthcare professional.

Adults: Refer to product-specific guidelines or consult a healthcare professional.

Pregnancy

There is limited data on the safety of Sunset during pregnancy, thus it should be used only if clearly needed and prescribed by a healthcare provider.

Breast-feeding

Due to the lack of sufficient studies, it is advised to consult a healthcare professional before using Sunset while breastfeeding.

Storage

Store in a cool, dry place, away from direct sunlight and out of reach of children.

Indications

• Magnetic resonance imaging (MRI) contrast enhancement
• Drug delivery systems
• Potential therapeutic applications in oncology

Dosage

Children: Refer to the BNF for Children for appropriate pediatric dosing information.

Adults: Refer to the specific guidelines for dosage as per BNF and clinical protocols.

Mechanism of action

The principal uptake mechanism for superparamagnetic iron oxide nanoparticles involves clathrin-mediated endocytosis that is dependent on scavenger receptor A. This process allows phagocytic cells, particularly macrophages, to internalize the nanoparticles effectively. The interaction of these nanoparticles with macrophages is critical for their application in imaging and potential therapeutic interventions.

Pharmacodynamics

Superparamagnetic iron oxide nanoparticles exhibit properties that enhance the visibility of tissues during imaging procedures. Their magnetic properties allow for a significant increase in contrast during MRI scans. Additionally, they may have implications in therapeutic contexts, such as in the targeting of cancer cells, where their uptake by macrophages could facilitate localized drug delivery.

Pharmacokinetics

The pharmacokinetics of superparamagnetic iron oxide nanoparticles are characterized by rapid uptake by phagocytic cells, particularly in the liver and spleen. Following systemic administration, these nanoparticles are primarily cleared by macrophages through endocytosis. The particles tend to accumulate in the reticuloendothelial system, which can influence their distribution and elimination from the body.

Pregnancy

There is limited data on the safety of iron oxide nanoparticles during pregnancy. Caution is advised.

Breast-feeding

Limited data is available regarding the excretion of iron oxide nanoparticles in breast milk. Caution is advised.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

• Carboxydextran-coated superparamagnetic iron oxide nanoparticles

Pregnancy

No specific data available, consult a healthcare professional.

Breast-feeding

No specific data available, consult a healthcare professional.

Storage

Store in a cool, dry place away from light.

Mechanism of action

Like all beta-lactam antibiotics, cefadroxil binds to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, causing the inhibition of the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefadroxil interferes with an autolysin inhibitor.

Pharmacodynamics

Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.

Mechanism of action

Although systemically applied nanoparticles are quickly taken up by phagocytic cells, mainly macrophages, the interactions between engineered nanoparticles and macrophages are still not well defined. ...Therefore ... the uptake of diagnostically used carboxydextran-coated superparamagnetic iron oxide nanoparticles of 60 nm (SPIO) and 20 nm (USPIO) by human macrophages /was analyzed/. By pharmacological and in vitro knockdown approaches, the principal uptake mechanism for both particles was identified as clathrin-mediated, scavenger receptor A-dependent endocytosis... /Iron oxide nanoparticles/ ... /It has been/ suggested that ferric oxide serves as a carcinogenic cofactor either by retarding the clearance of inhaled carcinogens or by inducing cytopathological changes which make the cells of the respiratory tract more prone to develop cancer when exposed to carcinogenic substances.